JD Health
VerifiedIs an e-commerce platform for pharmaceutical products such as vitamins & supplements (subsidiary of JD.com).
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$3.4b (Public information from Jul 2024)
Share price
HKD20.8 6618.HK
Beijing China (HQ)
Deals in current and previous year:
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 79 % | 58 % | 52 % | 15 % | 16 % | 17 % | 15 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (88 %) | (3 %) | 2 % | 6 % | 3 % | 4 % | 5 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (89 %) | (3 %) | 1 % | 4 % | 4 % | 4 % | 5 % |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 3 % | 3 % | 2 % | 2 % | - | - | - |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| investor investor investor | $0.0 Valuation: $0.0 | round | |
| investor | $0.0 Valuation: $0.0 4.7x EV/LTM Revenues -64.4x EV/LTM EBITDA | round | |
| N/A | $3.5b Valuation: $29.0b 19.4x EV/LTM Revenues -267.0x EV/LTM EBITDA | IPO | |
| Total Funding | 000k | ||
